DVA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The 5-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past five years. As of today (2025-07-06), DaVita's 5-Year Sharpe Ratio is 0.42.
For the Medical Care Facilities subindustry, DaVita's 5-Year Sharpe Ratio, along with its competitors' market caps and 5-Year Sharpe Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, DaVita's 5-Year Sharpe Ratio distribution charts can be found below:
* The bar in red indicates where DaVita's 5-Year Sharpe Ratio falls into.
The 5-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last five years. A stock / portfolio's 5-Year Sharpe Ratio can be calculated by dividing the difference between the five-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past five years.
DaVita (NYSE:DVA) 5-Year Sharpe Ratio Explanation
The 5-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past five years. It is calculated as the annualized result of the average five-year monthly excess returns divided by its standard deviation in the five-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.
The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.
Thank you for viewing the detailed overview of DaVita's 5-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Berkshire Hathaway Inc | 10 percent owner | 3555 FARNAM STREET, OMAHA NE 68131 |
Javier Rodriguez | officer: Chief Executive Officer, DKC | 601 HAWAII ST., EL SEGUNDO CA 90245 |
Joel Ackerman | officer: Chief Financial Officer | COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817 |
Michael David Staffieri | officer: Chief Operating Officer, DKC | 2000 16TH STREET, DENVER CO 80202 |
Kathleen Alyce Waters | officer: Chief Legal Officer | C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202 |
Barbara J Desoer | director | CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013 |
James O Hearty | officer: Chief Compliance Officer | 2000 16TH STREET, DENVER CO 80202 |
Christopher Michael Berry | officer: Chief Accounting Officer | C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103 |
Wendy Lee Schoppert | director | 6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442 |
Phyllis R Yale | director | |
Charles Berg | director, officer: Executive Chair, DMG | 48 MONROE TURNPIKE, TRUMBULL CT 06611 |
John M Nehra | director | 1119 ST PAUL ST, BALTIMORE MD 21202 |
Adam H Schechter | director | 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033 |
Jason M. Hollar | director | 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179 |
Paula A Price | director | ONE CVS DRIVE, WOONSOCKET RI 02895 |
From GuruFocus
By GuruFocus News • 05-19-2025
By GuruFocus News • 05-13-2025
By PRNewswire • 05-20-2025
By GuruFocus News • 04-14-2025
By GuruFocus News • 05-20-2025
By GuruFocus News • 05-19-2025
By PRNewswire • 04-30-2025
By ACCESSWIRE • 05-06-2025
By GuruFocus News • 05-13-2025
By GuruFocus News • 05-19-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.